San Francisco, California
United States
115
2025-01-30
The entities that hold a legal rights for patent applications filed by inventor Long Daniel D.:
Daniel D. Long from San Francisco, US has applied for patents for these inventions. The list has both pending applications and granted patents:
DIMETHYL AMINO AZETIDINE AMIDES AS JAK INHIBITORS
#2 | 2024-09-264-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS
#3 | 2023-10-12DIMETHYL AMINO AZETIDINE AMIDES AS JAK INHIBITORS
#4 | 2023-06-158-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS
#5 | 2022-09-01BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS
#6 | 2022-01-13Ester and carbonate pyrimidine compounds as JAK kinase inhibitors
#7 | 2021-06-17Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease
#8 | 2021-05-27Dimethyl amino azetidine amides as JAK inhibitors
#9 | 2021-02-04GLUCURONIDE PRODRUGS OF JANUS KINASE INHIBITORS
#10 | 2021-01-285 to 7 membered heterocyclic amides as JAK inhibitors
#11 | 2021-01-288-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
#12 | 2020-12-24Prodrugs of fencamfamine
#13 | 2019-12-26Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease
#14 | 2019-10-108-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
#15 | 2019-04-258-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
#16 | 2019-01-24Prodrugs of fencamfamine
#17 | 2018-11-29Glucuronide prodrugs of Janus kinase inhibitors
#18 | 2018-11-29Thiocarbamate prodrugs of tofacitinib
#19 | 2018-09-13Glucuronide prodrugs of tofacitinib
#20 | 2018-07-12NEPRILYSIN INHIBITORS
#21 | 2018-05-03Neprilysin inhibitors
#22 | 2018-02-224-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
#23 | 2017-12-078-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
#24 | 2017-11-23Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
#25 | 2017-07-06Neprilysin inhibitors
#26 | 2017-05-25Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease
#27 | 2017-05-18Neprilysin inhibitors
#28 | 2016-12-29Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
#29 | 2016-06-238-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
#30 | 2016-02-11Hepatitis C virus inhibitors
#31 | 2015-10-15Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
#32 | 2015-10-158-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
#33 | 2015-09-10Hepatitis C virus inhibitors
#34 | 2015-07-30Neprilysin inhibitors
#35 | 2015-07-30Neprilysin inhibitors
#36 | 2015-07-02Benzimidazole-carboxamide compounds as 5-HTreceptor agonists
#37 | 2015-03-12Inhibitors of hepatitic C virus
#38 | 2015-02-198-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
#39 | 2014-11-063-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#40 | 2014-09-258-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
#41 | 2014-06-12Quinolinone-carboxamide compounds as 5-HTreceptor agonists
#42 | 2014-03-208-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
#43 | 2014-02-274-[2-(2-fluorophenoxy methyl)phenyl]piperidine compounds
#44 | 2014-01-303-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#45 | 2013-10-31Hepatitis C virus inhibitors
#46 | 2013-10-31Piperazine-piperidine compounds as hepatitis C virus inhibitors
#47 | 2013-10-17BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS
#48 | 2013-06-208-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
#49 | 2013-05-09Hepatitis C virus inhibitors
#50 | 2013-03-28Process for preparing an intermediate to mu opioid receptor antagonists
#51 | 2013-02-14Aminotetralin compounds as mu opioid receptor antagonists
#52 | 2013-01-314-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
#53 | 2012-10-18Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
#54 | 2012-08-23Cross-linked glycopeptide-cephalosporin antibiotics
#55 | 2012-06-28Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#56 | 2012-05-10Inhibitors of hepatitis C virus
#57 | 2012-04-12Aminotetralin compounds as mu opioid receptor antagonists
#58 | 2012-04-123-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#59 | 2011-07-07Process for preparing an intermediate to mu opioid receptor antagonists
#60 | 2011-06-16Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
#61 | 2011-05-26Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
#62 | 2011-05-198-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
#63 | 2010-12-09Quinolinone-carboxamide compounds as 5-HTreceptor agonists
#64 | 2010-11-18Indazole-carboxamide compounds
#65 | 2010-11-11Quinolinone-carboxamide compounds as 5-HTreceptor agonists
#66 | 2010-10-14Indazole-carboxamide compounds as 5-HTreceptor agonists
#67 | 2010-09-30Benzimidazole-carboxamide compounds as 5-HTreceptor agonists
#68 | 2010-08-05Cross-linked glycopeptide-cephalosporin antibiotics
#69 | 2010-06-17Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
#70 | 2010-05-204-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
#71 | 2010-02-118-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists
#72 | 2009-10-01Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#73 | 2009-08-20Benzimidazole-carboxamide compounds as 5-HTreceptor agonists
#74 | 2009-06-113-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#75 | 2009-06-11Aminotetralin compounds as mu opioid receptor antagonists
#76 | 2009-05-28Cross-linked glycopeptide-cephalosporin antibiotics
#77 | 2009-03-05Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
#78 | 2009-03-05Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
#79 | 2009-03-058-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
#80 | 2009-03-05Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
#81 | 2009-02-05Quinolinone compounds as 5-HTreceptor agonists
#82 | 2009-01-22Process for preparing an intermediate to opioid receptor antagonists
#83 | 2008-10-165-HTreceptor agonist compounds
#84 | 2008-08-14Cross-linked glycopeptide-cephalosporin antibiotics
#85 | 2008-08-14Cross-linked glycopeptide-cephalosporin antibiotics
#86 | 2008-07-24Quinolinone-carboxamide compounds as 5-HT, receptor agonists
#87 | 2008-07-10Quinolinone-carboxamide compounds
#88 | 2008-06-19Indazole-carboxamide compounds as 5-HTreceptor agonists
#89 | 2008-06-05Indazole-carboxamide compounds
#90 | 2008-05-08Cross-linked glycopeptide-cephalosporin antibiotics
#91 | 2008-05-01Cephalosporin compounds
#92 | 2008-04-17Carbamate compounds as 5-HTreceptor agonists
#93 | 2008-03-20Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonists
#94 | 2008-02-21Cross-linked glycopeptide-cephalosporin antibiotics
#95 | 2008-02-14Cross-linked glycopeptide-cephalosporin antibiotics
#96 | 2008-02-14Cross-linked glycopeptide-cephalosporin antibiotics
#97 | 2007-12-06Quinolinone-carboxamide compounds as 5-HTreceptor agonists
#98 | 2007-11-22Quinolinone-carboxamide compounds as 5-HT, receptor agonists
#99 | 2007-09-208-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
#100 | 2007-05-24Carbamate compounds as 5-HTreceptor agonists
68633 ⎘